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Cerebroventricular Injection of 
Cigarette Smoke Condensate 
Produce Generalized Seizures 
Decreased by Muscarinic Receptor 
Antagonist in Rats
Jawad Laadraoui and Abderrahman Chait
Abstract
Tobacco smoke is a complex multicomponent system, in which more than 
4800 compounds have been identified by chromatographic techniques; many of 
these compounds are carcinogenic. However, there is a great deal of research into 
the association between smoking and diseases such as heart attacks, strokes and 
cancers. Nevertheless rare are the studies on the association between smoking 
and epilepsy because the exact roles of smoking and nicotine use in epilepsy have 
not been well examined. In this study the authors evaluate the convulsive effects 
of intracerebroventricular administration of cigarette smoke condensate in rats 
and compare intensity of seizures with kainic acid-induced seizures as a model of 
epilepsy. The role of cholinergic system was also evaluated using mAChRs antago-
nist in cigarette smoke condensate (CSC) induced seizures. Results indicate that 
central injection of cigarette condensate provides an epileptic behavior similar to 
that induced by kainic acid. However a pretreatment with atropine reduced seizures 
and all their parameters.
Keywords: seizures, epilepsy, cigarette smoke condensate, intracerebroventricular, 
kainic acid
1. Introduction
In the world, about 1% of people suffer from epilepsy [1]. Modern anticon-
vulsants can prevent and decrease the intensity of these convulsions. However, 
about 30% of people with epilepsy have uncontrollable seizures although of drugs 
availability. It is also known that the therapy ineffectiveness and chronic toxicity 
of antiepileptic drugs drawbacks the treatment procedure for nearly 20% of the 
patients [2].
Tobacco smoke is a complex multicomponent system, in which more than 4800 
compounds, many of which are known carcinogens. As a result, chronic obstructive 
pulmonary disease, chronic bronchitis, cardiovascular disease, emphysema, stroke 
and many forms of cancer are directly related to smoking [3].
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In March 2012, the Food and Drug Administration established a long list con-
taining 93 harmful and potentially harmful components (HPHCs) and an abbrevi-
ated list containing 18 HPHCs in tobacco products and tobacco smoke (Table 1).
However, seizure control in the majority of epileptic patients is achieved pri-
marily through the pharmacotherapeutic action of drugs targeting membrane ion 
channels or glutamatergic or gabaergic neurotransmission [4], which is dependent 
on a wide variety of modifications., glutamate and GABA [5]. For example, a weak 
activation of the GABAergic system induces epilepsy [6]. Generally, the risk of 
epilepsy should be higher in chronic tobacco smokers; this behavior is due to toxic 
components of tobacco smoke that can lead to seizure behavior in humans and 
animals [7, 8].
Many components in tobacco smoke are associated with seizures or epilepsy 
(Table 2) [9]. For example, nicotine, when overdosed, caused seizures in human 
subjects. Nicotine, a parasympathomimetic alkaloid in tobacco when overdosed, 
caused seizures in human [10]. The carbon monoxide causes seizures that can 
be focal or generalized and may even present as a status of epilepticus [11, 12]. 
Ammonia, hexane, lead, cresol, arsenic, toluene and acetone are other chemicals 
found in tobacco smoke that can trigger seizures in humans or animals [13].
HPHCs in cigarette smoke HPHCs in smokeless 
tobacco
HPHCs in roll-your-own tobaccoa and 
cigarette filler
Acetaldehyde Acetaldehyde Ammonia
Acrolein Arsenic Arsenic
Acrylonitrile Benzo[a]pyrene Cadmium
4-Aminobiphenyl Cadmium Nicotine (total)
1-Aminonaphthalene Crotonaldehyde NNK*
2-Aminonaphthalene Formaldehyde NNN**
Ammonia Nicotine (total and free)
Benzene NNK*
Benzo[a]pyrene NNN**
1,3-Butadiene
Carbon monoxide
Crotonaldehyde
Formaldehyde
Isoprene
Nicotine (total)
NNK*
NNN**
Toluene
See Ref. [4].*4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone.
**N-Nitrosonornicotine.
aRoll-your-own tobacco is defined in section 900(15) of the FD&C Act to mean “any tobacco product which, because 
of its appearance, type, packaging, or labeling, is suitable for use and likely to be offered to, or purchased by, consumers 
as tobacco for making cigarettes.” The term cigarette filler is not defined in the FD&C Act. For purposes of this draft 
guidance, we intend cigarette filler to mean the cut, ground, powdered, or leaf tobacco that is a component of a 
cigarette.
Table 1. 
Abbreviated list of harmful and potentially harmful constituents (HPHCs) in tobacco products.
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Animals have been a useful tool for elucidating the association between tobacco 
smoking or nicotine use and seizures or epilepsy. Nicotine induced seizure models 
include cats, mice, and rats, and it was reported that animals received nicotine via 
injection develop seizures but not through the automatic smoking machine (ASM) 
[14, 15]. Other studies have shown that the activity of seizure-inducing chemicals 
such as pentylenetetrazole [16], kainic acid, pilocarpine, had been enhanced by 
prior pretreatment with nicotine [17].
In this study, we have investigated the convulsive effect of CSC as a crisis model 
compared to the intensity of the kainic acid model of epilepsy in rats. Thus examine 
the role of the cholinergic system in cigarette condensate seizures using a treatment 
with cholinergic muscarinic ligand.
2.  Epileptic behavior induced by cerebral injection of cigarette smoke 
condensate
2.1 Methodology
The objective of the experiment was to demonstrate that a treatment with 
cigarette smoke condensate provides an epileptic behavior similar to this induced by 
a kainic acid, who reduced by a pretreatment with atropine.
The preparation of the cigarette smoke condensate was carried out by a cooling 
system consisting of a VP800 vacuum pump that generates and removes cigarette 
smoke to a tube and a balloon where the cigarette condensate is recovered [13]. Male 
Chemicals in 
tobacco smoke
Seizure-inducing Potentiating seizures
Nicotine Nicotine patch (H)a
Carbon monoxide (H)
5% carbon dioxide Low dose increased the severity of the electroshock-
induced seizures (M)
Arsenic
Ammonia (H), (R)
Hexane (H)
Lead acetate High dose induced 
forelimb
Potentiated PTZ-induced convulsions (M)
Toluene clonus (M) Increased susceptibility to aminophylline-induced 
seizures (IP) (M)
Cresol (H)
Selenium
Zinc
Copper
Nickel
Acetone High dose caused 
seizures
(M)
aH: human; M: mouse; R: rat.
Table 2. 
Effects of chemicals in tobacco smoke on seizures or epilepsy.
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Sprague-Dawley rats (3–4 months old, 230–250 g weight) were used in this experi-
ment, All animals were treated according to European decree, related to the ethical 
evaluation and authorization of projects using animals for experimental proce-
dures, 1st February 2013, NOR: AGRG1238767A efforts were made to minimize the 
number and suffering of animals used. Before the experience all rats are anesthe-
tized with an intraperitoneal injection of Hydrate chloral (400 mg/kg (6%)), before 
being placed in a Horsley-Clarke stereotactic frame. The head is secured with two 
bars that are inserted into the ear canal to the inner ears. The muzzle is well fixed by 
an oral part. After shaving the head, we made a median skin incision 1.5 cm long. 
The skin is spread laterally to clear the bone surface and highlight the coronal suture 
with the points, Bregma forward and Lambda back. The coordinates of the injection 
point with respect to the Bregma point are determined using the stereotaxic atlas 
of Paxinos and Watson [18]. The stereotaxic coordinates of the ventricle were as 
follows: the incisor bar −0.92 mm behind Bregma, ±1.5 mm laterally to the sagittal 
suture and 3.2 mm from the top of the skull. With a suitable milling machine, small 
openings are made in the cranial box for the placement (unilaterally) of the guide 
cannulas of approximately 23 gauge and the stainless steel anchor screws that will 
fix these cannulas. Stainless steel stylets (30 gauges) are placed in each guide can-
nula to prevent obstruction. These cannulas are then fixed by white dental cement. 
Then, with the help of pink dental cement, we put a crown in order to protect this 
preparation against any collision with the walls of the cage in which the animals 
were placed for 8 days to recover from surgery and eliminate anesthesia [13].
The animals were divided into four groups of six animals each. Control (saline 9%), 
kainic acid (1 μl/rat), CSC extract (2 μl/rat), atropine + CSC (Atr + CSC), a CSC was 
injected before 30 min of intraperitoneally injection of atropine (1 ml/kg).
For the KA and CSC infusion, the animals were gently retained by hand and the 
styles were removed from the guide cannulae and introduced 27 gauge injection 
needles. Injection was carried out using a Hamilton syringe (10 μl) which is con-
nected to an injection cannula by a polyethylene catheter filled with distilled water. 
This was lowered into the guide cannula to a distance of 1.5 mm below its lower end 
to reach the target structure.
Total volume of 1 μl/rat for kainic acid and 2 μl/rat for CSC injected solutions 
were administered for a period of 60 s, and then the injection needles were left in 
the guide cannulae for a supplementary period of 60 s to facilitate drug delivery.
The animals were placed in the convulsion cage for 1 day before the beginning of 
the experiment to adapt the animals in the new environment.
A seizure was caused by intracerebroventricular injection of kainic acid and 
SCC. Immediately after the injection, each rat was placed in the center of the cage 
and its behavior was recorded and monitored within 90 min. The epileptic and 
mortality behaviors observed were classified as follows: latency of the seizure, 
latency of the tonic-clonic seizure, duration of the tonic-clonic seizure [13].
The scoring of seizures severity after KA injection was recorded during observa-
tion period (90 min) according to the scale:
0: normal activity; 1: immobility and/or staring; 2: rigidity, extension of the 
tail, swaying of the head; 3: repetitive movements, bilateral paws, breeding, tremor 
of hind limbs; 4: minor or flickering convulsions, jumps, falls; 5: tonic-clonic or 
multiple convulsions and/or appearance of score 4; 6: severe tonic-clonic seizure; 7: 
death [13].
The rats were randomly tested and to avoid the presence of odors that could lead 
to a change in behavior the convulsive cage was cleaned at the end of each test. Each 
rat has been subjected to a seizure test only once, and seizures have always occurred 
between 1:00 pm and 4:00 pm to minimize the confusional effects of the circadian 
rhythm [19].
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2.2 Results
The results indicate that cigarette smoke condensate causes similar seizure 
behavior to this induced by kainic acid. However, the atropine-treated group showed 
a significant decrease in the convulsion score compared to the kainic acid group 
(Figure 1). There were no significant differences between the kainic acid and group 
treated with CSC concerning the time latency of seizures. However this parameter 
was significantly increased after treatment with atropine (Figure 2) [13].
Regarding to the latency of tonic-clonic seizures, the atropine-pretreated group 
showed a maximum value of score, which decreased significantly in the CSC group 
(Figure 3). However duration of tonic-clonic seizures was significantly decreased 
in the group pretreated with atropine compared to kainic acid and CSC groups. 
Nevertheless there is no significant deference between kainic acid and the CSC 
treated groups in the latency and duration of tonic-clonic seizures (Figure 4) [13].
2.3 Discussion
In this study, the authors explore the effects of intracerebroventricular pretreat-
ment with tobacco smoke condensate on seizures and compare its severity to the 
administration of chemical-induced seizures, such as kainic acid as an important 
agent for the studying the function related to the excitatory transmission of amino 
acid-like neurotoxic powerful glutamate used in the rat [20]. The main finding of 
our study was that the central injections of CSC induce an epileptically behavior 
in rats. Furthermore, time latency of seizures; duration and latency of tonic-clonic 
seizures were significantly similar in the experimental groups. The modulation 
of the cholinergic system in the rat brain by activation or blockade of cholinergic 
receptors using atropine as a cholinergic antagonist has shown us the pathway and 
mechanism by which the preparation of SCC generates epileptic behavior. In this 
case, our results indicate that pretreatment with atropine reduced the intensity of 
seizures as well as other parameters recorded in the rat.
Nicotine is a major alkaloid in tobacco smoke, cigarette smoking has been 
the most famous method to intake nicotine [9]. Several laboratory studies were 
found that administration of low dose of nicotine produces behavioral effects 
Figure 1. 
Total seizure scores of all the groups. Rats received intracerebroventricularly administration of a cigarette 
smoke condensate (CSC), kainic acid and cigarette smoke condensate after intraperitoneally administration 
of atropine (atropine + CSC). Mean ± SEM: ***P < 0.001 significantly different from the kainic acid group. 
+++P < 0.001 significantly different from CSC extract.
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like nociception [21], locomotor activity [22], memory, learning, attention 
[23] and decrease or reduce anxiety [24], whereas high doses of nicotine cause 
seizures [25–27].
In our study, the central administration of CSC induces an epileptic behavior 
manifested by tonic-clonic seizures similar to this provoked by kainic acid. These 
results according to several electrophysiological studies indicated that intracere-
broventricular administration of nicotine produces tonic-clonic seizures that have 
origin in the hippocampus structure [23, 25, 27].
Biochemical and pharmacological data have suggested that implicates the 
contribution of α4β2 and α7-containing nAChRs situated in GABAergic interneu-
ron, in the generation of nicotine induced seizures [25, 28]. Conti-Tronconi et al. 
[29] had proposed that α7-nAChR subtype to underlie nicotine induced seizures 
for the reason that seizures sensibility is significantly correlates with quantity 
of α-bungarotoxin binding sites exists in the hippocampus. Several studies have 
examined to define the interrelationship between the nicotinic cholinergic system 
Figure 2. 
Effect of intracerebroventricularly administration of kainic acid and cigarette smoke condensate (CSC) on 
latency of seizures. Mean ± SEM: **P < 0.01 significantly different from the kainic acid group. +++P < 0.001 
significantly different from CSC extract.
Figure 3. 
Total duration of seizures after intracerebroventricularly administration of kainic acid and cigarette 
smoke condensate (CSC), in a 90 min total time of epileptic behaviors recording. Mean ± SEM. **P < 0.01 
significantly different from CSC extract.
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with the excitatory glutamatergic system and inhibitory gabaergic neurotransmit-
ter in the brain. New study have reported that the α7-containing nAChRs receptors 
activation situated on glutamatergic nerve terminal conducing to synaptic libera-
tion of glutamate which in turn stimulate N-methyl-d-Aspartate (NMDA) receptors 
located on pyramidal cells in of the hippocampus, are the most important mecha-
nism that leads to nicotine seizures [25]. Though, other studies have demonstrated 
the contribution of α4β2 as well as α7-containing nAChRs receptors, localized 
in gabaergic interneurons in the creation of nicotine induced seizures [28, 30]. 
Contradictory to the glutamatergic hypothesis mentioned above, Dobelis et al. [28], 
proposed that nicotine-induced excitation was principally on relationship of 
pyramidal cells disinhibition in the hippocampus due to desensitization of α4β2 
nAChR subtype situated on the cell bodies and dendritic terminals of pre-synaptic 
gabaergic interneurons.
Our results also indicate that pretreatment with atropine, a cholinergic blocking 
agent decreased score and latency of total seizures and tonic-clonic seizures of CSC-
induced seizures; this experiment indicate that cholinergic circuit have an essential 
role in the mechanism underling the generation of seizures by cigarette smoke 
condensate. Supporting to this finding, numerous studies reporting that atropine 
acts as an anticonvulsant tool reducing the incidence and effectiveness of convul-
sions induced by an organophosphorus nerve agent [31]. A new study reporting that 
the anticonvulsant effects of atropine diminished with the seizures progression in 
a soman-induced seizures model in rats. This anticonvulsant action vanishes when 
the seizures had persisted for a period of 40 min [32]. Gholami et al. [33] reported 
a significant effect of cholinergic ligand in the pentylenetetrazole-induced epilepsy 
model in the rat hippocampus and they founded that cholinergic agonists leads 
to an augmentation of tonic-clonic seizures severity and rate mortality, however 
cholinergic antagonist decrease duration of tonic-clonic seizures, these data are in 
agreement with our study.
3. Conclusion
Data had revealed that the intracerebroventricular injection of CSC induces 
tonic and clonic seizures characterizing epieltical behavior similar to this triggered 
Figure 4. 
Duration of tonic-clonic seizure after intracerebroventricularly administration of kainic acid and cigarette 
smoke condensate (CSC). Mean ± SEM: **P < 0.01 significantly different from the kainic acid group. ++P < 0.01 
significantly different from CSC extract.
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© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
by acid kainic model of seizures and a significant modulatory effect of cholinergic 
antagonist ligands in the CSC induced seizures. In this epilepsy model, CSC led to 
an increment of time latency, duration and latency of tonic-clonic seizures; while 
pretreatment with cholinergic antagonist increased all parameters recorded. This 
finding provide supplementary support for data that tobacco and specially nicotine 
had convulsing actions and confirmation of novel CSC induced seizures model of 
epilepsy in rats.
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